1. Home
  2. VNRX vs NNVC Comparison

VNRX vs NNVC Comparison

Compare VNRX & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$2.47

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.47

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
NNVC
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
21.2M
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
VNRX
NNVC
Price
$2.47
$1.47
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$1.67
N/A
AVG Volume (30 Days)
1.8M
287.0K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
10.00
EPS
N/A
N/A
Revenue
$1,727,384.00
N/A
Revenue This Year
$355.66
N/A
Revenue Next Year
$849.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.04
N/A
52 Week Low
$0.13
$0.85
52 Week High
$2.89
$2.23

Technical Indicators

Market Signals
Indicator
VNRX
NNVC
Relative Strength Index (RSI) 81.68 66.99
Support Level $0.22 $1.35
Resistance Level $2.89 $1.53
Average True Range (ATR) 0.15 0.13
MACD 0.20 0.02
Stochastic Oscillator 82.83 73.33

Price Performance

Historical Comparison
VNRX
NNVC

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: